Related Experiment Video
Updated: Feb 19, 2026
07:53
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
11.6K
Cellulose-based Nanocarriers as Platforms for Cancer Therapy
Ling-Yan Meng1, Bin Wang1, Ming-Guo Ma1,2
1Engineering Research Center of Forestry Biomass Materials and Bioenergy, Beijing Key Laboratory of Lignocellulosic Chemistry, College of Materials Science and Technology, Beijing Forestry University, Beijing 100083, P.R. China.
Current Pharmaceutical Design
|November 1, 2017
Summary
Cellulose nanocarriers show promise for cancer therapy. This review covers their development, synthesis, and properties for drug delivery, highlighting future directions.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Polymer Chemistry
Background:
- Cellulose is a renewable, eco-friendly polymer with diverse applications.
- Cellulose derivatives are increasingly explored for biomedical uses, including cancer therapy.
- Nanocarriers are crucial for effective drug delivery systems.
Purpose of the Study:
- To review the latest advancements in cellulose-based nanocarriers for cancer therapy.
- To summarize synthesis strategies and properties of these nanocarriers.
- To discuss current challenges and future prospects in the field.
Main Methods:
- Literature review of recent studies on cellulose-based nanocarriers for cancer treatment.
- Analysis of various cellulose nanocarrier types, including bacterial cellulose (BC), cellulose acetate, and cellulose nanocrystals.
- Examination of synthesis methods and structural-property relationships.
Main Results:
- Diverse cellulose-based nanocarriers (e.g., BC, cellulose nanocrystals) are effective in drug delivery for cancer.
- Various synthesis strategies exist for tailoring nanocarrier properties.
- Structure and properties are key to their performance in cancer therapy.
Conclusions:
- Cellulose-based nanocarriers offer a promising platform for cancer drug delivery.
- Further research is needed to overcome existing challenges and optimize their clinical application.
- Future developments will focus on enhancing efficacy and safety for cancer treatment.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
31
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
31
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
01:24Modified-Release Drug Delivery Systems: Site-Targeted
29
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
29